Aquestive Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | 33.8% | 33.8% | -20.7% |
| FY2018 | -608.9% | -608.9% | -70.7% |
| FY2019 | 1,082.1% | -103.7% | -84.4% |
| FY2020 | 115.0% | -1,857.6% | -88.7% |
| FY2021 | 85.9% | 85.9% | -113.8% |
| FY2022 | 45.9% | 63.9% | -95.3% |
| FY2023 | 7.4% | 12.8% | -13.7% |
| FY2024 | 73.4% | 291.2% | -43.5% |
| FY2025 | 248.9% | -739.0% | -52.2% |